Product Details
CJC-1295 (with DAC) is a long-acting growth hormone releasing hormone analog used in research settings focused on endocrine signaling and peptide pharmacokinetic design. Within our metabolic peptides catalog, we position CJC-1295 (with DAC) around the functional roles of GHRH analog, Endocrine signaling research peptide, Extended-circulation model so commercial buyers can compare the peptide against similar sourcing options.
This peptide is studied for interaction with growth hormone releasing hormone receptor pathways, while the DAC modification is used to extend circulation time in experimental systems. In formulation and laboratory sourcing workflows, it is commonly referenced for Endocrine pathway research, Long-acting peptide design studies, Experimental peptide programs, which helps buyers align product context before requesting pricing or documentation.
Key characteristics include DAC-modified structure; Long-acting research format; High-interest peptide model. We supply CJC-1295 (with DAC) in pack sizes such as 2 mg vial, 5 mg vial, 10 mg vial, Bulk API, with MOQ 10 units, 4-7 business days lead times, Atlas Labs quality review, and documentation support. Typical release profile: >=99% by HPLC with identity verification. Release packet includes lot traceability references.
Explore the Metabolic Peptides category page for comparable options, then submit a prefilled quote request to confirm sourcing, pricing, and lead time alignment.